Presentation of the Q1 Interim report 2023

Oncopeptides AB (publ) published the report for the first quarter 2023, at 08.00 (CET) on Thursday May 4, 2023. Investors, financial analysts, and media were invited to participate in a webcast and a following QnA session at 09.00 (CET) on the same day.

The presentation was hosted by Monica Shaw, CEO, together with Holger Lembrér, CFO, and was held in English. The presentation was recorded and the PDF-version of the presentation is published below.

Link to the recorded webcast:

https://ir.financialhearings.com/oncopeptides-q1-2023